United States · FDA National Drug Code directory
NYSTATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69315-504_eb4efca9-e5e8-4509-9437-6ad7c593a9ef
- Product NDC
- 69315-504
- Form
- SUSPENSION
- Composition / generic term
- NYSTATIN
- Labeler
- Leading Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221205
- Source listing expiry
- 20261231
Source-listed ingredients
- NYSTATIN — 100000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE (69315-504-47) · 69315-504-47
- 1 BOTTLE in 1 PACKAGE (69315-504-60) / 60 mL in 1 BOTTLE · 69315-504-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →